Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-11

Clinical Trial Update: Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating topiramate for individuals with alcohol use disorder and binge eating disorder have been completed; results were posted on 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

Sponsor: University of Virginia | Conditions: Alcohol Dependence, Binge Eating | Phase 2 | Status: COMPLETED | Results posted: 2017-05-11